Lewis C Cantley Selected Research

Erlotinib Hydrochloride (CP 358,774)

5/2007	MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.
10/2006	Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer.
8/2005	Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lewis C Cantley Research Topics

Disease

165	Neoplasms (Cancer) 05/2024 - 07/2002
23	Breast Neoplasms (Breast Cancer) 01/2023 - 12/2005
14	Neoplasm Metastasis (Metastasis) 01/2024 - 07/2010
14	Carcinogenesis 01/2020 - 03/2008
13	Lung Neoplasms (Lung Cancer) 02/2024 - 08/2005
12	Insulin Resistance 12/2019 - 01/2002
9	Obesity 01/2023 - 03/2007
8	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 09/2008
7	Pancreatic Neoplasms (Pancreatic Cancer) 12/2020 - 04/2013
6	Tuberous Sclerosis (Bourneville's Disease) 02/2022 - 07/2002
6	Adenocarcinoma 01/2022 - 04/2013
6	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 08/2010
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 03/2005
5	Brain Neoplasms (Brain Tumor) 02/2024 - 12/2009
5	Body Weight (Weight, Body) 01/2023 - 06/2004
5	COVID-19 01/2023 - 05/2020
5	Carcinoma (Carcinomatosis) 04/2022 - 10/2006
5	Triple Negative Breast Neoplasms 01/2022 - 01/2016
5	Type 2 Diabetes Mellitus (MODY) 12/2019 - 06/2004
4	Adenocarcinoma of Lung 05/2024 - 10/2006
4	Glioblastoma (Glioblastoma Multiforme) 02/2024 - 01/2012
4	Endometrial Neoplasms (Endometrial Cancer) 04/2022 - 07/2011
4	Melanoma (Melanoma, Malignant) 01/2017 - 12/2011
3	Starvation 02/2024 - 03/2012
3	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 09/2010
3	Bites and Stings (Sting) 01/2021 - 01/2018
3	Hypersensitivity (Allergy) 08/2013 - 03/2005
3	Crohn Disease (Crohn's Disease) 07/2012 - 12/2004
3	Inborn Genetic Diseases (Disease, Hereditary) 09/2005 - 10/2002

Drug/Important Bio-Agent (IBA)

31	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 01/2002
28	Phosphotransferases (Kinase)IBA 05/2024 - 03/2004
25	Insulin (Novolin)FDA Link 01/2024 - 01/2002
22	Proteins (Proteins, Gene)FDA Link 03/2024 - 10/2002
22	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2023 - 01/2002
16	EnzymesIBA 02/2024 - 06/2004
15	Protein Isoforms (Isoforms)IBA 01/2023 - 03/2008
14	Pyruvate KinaseIBA 01/2022 - 03/2008
12	Serine (L-Serine)FDA Link 01/2020 - 05/2009
11	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2023 - 07/2002
9	Glutamine (L-Glutamine)FDA Link 01/2016 - 08/2010
8	LipidsIBA 05/2024 - 05/2009
8	ErbB Receptors (EGF Receptor)IBA 12/2015 - 03/2005
7	TOR Serine-Threonine KinasesIBA 09/2010 - 10/2002
6	Amino Acids FDA Link 02/2024 - 05/2009
6	NVP-BKM120IBA 12/2023 - 11/2012
6	Metformin (Glucophage)FDA LinkGeneric 12/2023 - 12/2005
6	CytokinesIBA 01/2023 - 12/2004
6	phosphatidylinositol 5-phosphateIBA 01/2023 - 06/2004
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2012
6	FructoseIBA 03/2021 - 01/2013
6	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 03/2002
6	NucleotidesIBA 01/2017 - 09/2007
5	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 05/2024 - 03/2004
5	Tuberous Sclerosis Complex 2 ProteinIBA 02/2022 - 07/2002
5	SugarsIBA 01/2022 - 01/2012
5	Hormones (Hormone)IBA 01/2022 - 11/2005
5	AlpelisibIBA 01/2022 - 01/2017
5	Fatty Acids (Saturated Fatty Acids)IBA 11/2021 - 01/2013
5	Phosphoglycerate Dehydrogenase (Dehydrogenase, Phosphoglycerate)IBA 01/2020 - 07/2011
5	Small Interfering RNA (siRNA)IBA 01/2020 - 03/2008
5	Mechanistic Target of Rapamycin Complex 1IBA 09/2015 - 09/2008
4	Ascorbic Acid (Vitamin C)FDA LinkGeneric 06/2023 - 12/2015
4	Phosphoric Monoester Hydrolases (Phosphatases)IBA 06/2023 - 07/2004
4	LeptinIBA 01/2023 - 05/2008
4	Transcription Factors (Transcription Factor)IBA 12/2022 - 03/2002
4	VaccinesIBA 10/2022 - 08/2004
4	MK 2206IBA 04/2022 - 01/2019
4	Tuberous Sclerosis Complex 1 ProteinIBA 02/2022 - 10/2002
4	CarbohydratesIBA 01/2022 - 10/2015
4	Oxaloacetic Acid (Oxalacetic Acid)IBA 12/2020 - 01/2018
4	Transaminases (Aminotransferases)IBA 12/2020 - 01/2018
4	Glutamic Acid (Glutamate)FDA Link 12/2020 - 01/2018
4	CarbonIBA 01/2020 - 07/2011
4	trans-sodium crocetinate (crocetin)IBA 09/2015 - 10/2002
4	IsoenzymesIBA 06/2013 - 02/2010
4	Gefitinib (Iressa)FDA Link 05/2007 - 03/2005
4	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 05/2007 - 01/2002
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2024 - 12/2005
3	Peptides (Polypeptides)IBA 02/2024 - 03/2008
3	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2018
3	Histones (Histone)IBA 01/2023 - 12/2014
3	Protein Kinases (Protein Kinase)IBA 10/2022 - 10/2009
3	tyrosine receptor (receptor, tyrosine)IBA 01/2022 - 09/2011
3	olaparibIBA 01/2022 - 11/2012
3	ChemokinesIBA 01/2021 - 05/2007
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 12/2008
3	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2020 - 07/2011
3	Oxygen (Dioxygen)IBA 01/2019 - 11/2009
3	Letrozole (Femara)FDA LinkGeneric 01/2019 - 04/2014
3	Everolimus FDA Link 07/2017 - 09/2008
3	MTOR InhibitorsIBA 03/2017 - 07/2004
3	Tyrosine Kinase InhibitorsIBA 01/2017 - 08/2005
3	Drug CombinationsIBA 01/2017 - 07/2011
3	Messenger RNA (mRNA)IBA 12/2015 - 02/2010
3	Lactic Acid (Lactate)FDA LinkGeneric 07/2011 - 11/2009
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2009 - 08/2005
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2007 - 08/2005
2	ThioredoxinsIBA 03/2024 - 02/2024

Therapy/Procedure

60	Therapeutics 01/2024 - 03/2004
3	Radiotherapy 04/2022 - 01/2020